Evidence map›Paper›PMID 42279613›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Prognostic Role of Inflammatory Indices and Real-World Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine.

Taliha Güçlü Kantar, Tolga Doğan, Semra Taş, Bedriye Açıkgöz Yıldız, Gamze Serin Özel, Ceren Mordağ Çiçek, Ahmet Ali Kantar, Burcu Yapar Taşköylü, Atike Gökçen Demiray, Tarık Şengöz and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Taliha Güçlü KantarDepartment of Medical Oncology, Denizli State Hospital, Denizli 20070, Türkiye.ORCID 0000-0002-7836-4272
Tolga DoğanDepartment of Medical Oncology, Denizli State Hospital, Denizli 20070, Türkiye.ORCID 0000-0003-1281-942X
Semra TaşDepartment of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, Türkiye.
Bedriye Açıkgöz YıldızDepartment of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, Türkiye.ORCID 0000-0001-7976-3358
Gamze Serin ÖzelDepartment of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, Türkiye.ORCID 0009-0002-3631-6771
Ceren Mordağ ÇiçekDepartment of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, Türkiye.ORCID 0000-0002-9140-1453
Ahmet Ali KantarDepartment of Nuclear Medicine, School of Medicine, Pamukkale University, Denizli 20070, Türkiye.
Burcu Yapar TaşköylüDepartment of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, Türkiye.
Atike Gökçen DemirayDepartment of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, Türkiye.
Tarık ŞengözDepartment of Nuclear Medicine, School of Medicine, Pamukkale University, Denizli 20070, Türkiye.ORCID 0000-0003-2621-7585
Özgür TanrıverdiDepartment of Medical Oncology, School of Medicine, Muğla University, Mugla 48000, Türkiye.ORCID 0000-0002-0598-7284
Arzu YarenDepartment of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, Türkiye.
Gamze Gököz DoğuDepartment of Medical Oncology, School of Medicine, Pamukkale University, Denizli 20070, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CRP/albumin ratioHER2-positive metastatic breast cancerinflammatory indicesneutrophil-to-lymphocyte ratioreal-world outcomesT-DM1

Identifiers

PMID42279613
PMCPMC13256335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.